Neuroendocrine tumors (NETs) are rare neoplasms arising from the diffuse neuroendocrine system that can range from indolent to highly aggressive diseases. They usually clinically manifest when reaching a significant size or when hepatic metastases develop, leading to overproduction and impaired hepatic metabolism of vasoactive substances. The clinical course of NETs may be complicated by cardiac involvement, known as carcinoid heart disease (CHD), predominantly affecting the right side of the heart. CHD is characterized by specific echocardiographic features, including thickening, reduced excursion and retraction of valvular leaflets, resulting in valvular stenosis or regurgitation. Despite its clinical relevance, awareness of CHD as a complex hormonal sequela of NETs remains limited among cardiologists, and its echocardiographic findings are not universally recognized. This review aims to (a) provide cardiologists with the main principles for understanding CHD pathophysiology; (b) illustrate the main echocardiographic features of CHD, using a stepwise approach; and (c) refine a diagnostic algorithm for detecting cardiac involvement in NET populations and identifying patients at high risk of developing CHD.
{"title":"Carcinoid Heart Disease: The Role of Echocardiography in Raising the First Suspicion.","authors":"Silvia Stavagna, Giovanna Manzi, Danilo Angotti, Andrea D'Amato, Elisa Giannetta, Roberto Badagliacca, Federico Ciccarelli, Lucrezia Netti, Paolo Severino, Wael Saade, Carmine Dario Vizza, Viviana Maestrini","doi":"10.3390/jcm15051978","DOIUrl":"10.3390/jcm15051978","url":null,"abstract":"<p><p>Neuroendocrine tumors (NETs) are rare neoplasms arising from the diffuse neuroendocrine system that can range from indolent to highly aggressive diseases. They usually clinically manifest when reaching a significant size or when hepatic metastases develop, leading to overproduction and impaired hepatic metabolism of vasoactive substances. The clinical course of NETs may be complicated by cardiac involvement, known as carcinoid heart disease (CHD), predominantly affecting the right side of the heart. CHD is characterized by specific echocardiographic features, including thickening, reduced excursion and retraction of valvular leaflets, resulting in valvular stenosis or regurgitation. Despite its clinical relevance, awareness of CHD as a complex hormonal sequela of NETs remains limited among cardiologists, and its echocardiographic findings are not universally recognized. This review aims to (a) provide cardiologists with the main principles for understanding CHD pathophysiology; (b) illustrate the main echocardiographic features of CHD, using a stepwise approach; and (c) refine a diagnostic algorithm for detecting cardiac involvement in NET populations and identifying patients at high risk of developing CHD.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"15 5","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12986470/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147457700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Liat Mor, Ohad Gluck, Amit Kreiner, Ram Kerner, Shimon Ginath, Ran Keidar, Ron Sagiv
Background: Postpartum complications requiring surgical intervention are challenging due to physiologic and anatomic changes. While laparotomy remains standard, laparoscopy is increasingly used. We compared outcomes of laparoscopic management of postpartum complications versus open management of postpartum complications. Methods: This retrospective cohort study included patients undergoing surgical intervention within three weeks postpartum at a single tertiary center between 2010 and 2023. Approach selection was primarily time-dependent, following an institutional practice change in 2020. Demographic, operative, and postoperative outcomes were compared. Results: Sixty-two participants with postpartum complications necessitating surgical intervention were included: 54 in the laparotomy group and 8 who underwent laparoscopy. Demographic characteristics were similar between groups. The main indication for laparoscopy was suspected uterine scar defects (p = 0.006), while laparotomy was obtained mainly in cases of suspected bleeding (p = 0.001). Both groups had comparable operative time, though the laparoscopy group had a shorter postoperative admission (p = 0.043). Conclusions: Laparoscopy is feasible for various postpartum complications. It offers comparable operative times to laparotomy with shorter postoperative admissions. Therefore, it is a promising alternative in selected cases when surgical expertise is available.
{"title":"Laparoscopy vs. Laparotomy for Management of Postpartum Complications-A Retrospective Cohort Study.","authors":"Liat Mor, Ohad Gluck, Amit Kreiner, Ram Kerner, Shimon Ginath, Ran Keidar, Ron Sagiv","doi":"10.3390/jcm15051982","DOIUrl":"10.3390/jcm15051982","url":null,"abstract":"<p><p><b>Background:</b> Postpartum complications requiring surgical intervention are challenging due to physiologic and anatomic changes. While laparotomy remains standard, laparoscopy is increasingly used. We compared outcomes of laparoscopic management of postpartum complications versus open management of postpartum complications. <b>Methods:</b> This retrospective cohort study included patients undergoing surgical intervention within three weeks postpartum at a single tertiary center between 2010 and 2023. Approach selection was primarily time-dependent, following an institutional practice change in 2020. Demographic, operative, and postoperative outcomes were compared. <b>Results:</b> Sixty-two participants with postpartum complications necessitating surgical intervention were included: 54 in the laparotomy group and 8 who underwent laparoscopy. Demographic characteristics were similar between groups. The main indication for laparoscopy was suspected uterine scar defects (<i>p</i> = 0.006), while laparotomy was obtained mainly in cases of suspected bleeding (<i>p</i> = 0.001). Both groups had comparable operative time, though the laparoscopy group had a shorter postoperative admission (<i>p</i> = 0.043). <b>Conclusions:</b> Laparoscopy is feasible for various postpartum complications. It offers comparable operative times to laparotomy with shorter postoperative admissions. Therefore, it is a promising alternative in selected cases when surgical expertise is available.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"15 5","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12985969/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147457800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background/Objectives: Posterior reversible encephalopathy syndrome (PRES) is a neurological condition characterized by acute neurological symptoms and vasogenic edema, usually affecting the posterior circulation. It is described in end-stage renal disease (ESRD), but its presentation in peritoneal dialysis (PD) is not well defined. We aimed to describe the clinical, radiological, and dialysis-related features of PRES in PD patients and highlight factors relevant for diagnosis and management. Materials and Methods: We conducted a retrospective descriptive case series of four ESRD patients on PD or recently transitioned from PD to hemodialysis (HD) who developed PRES at a single center. Clinical data, laboratory results, dialysis characteristics, and neuroimaging findings were obtained from medical records. PRES was diagnosed based on acute neurological symptoms in the setting of severe hypertension and uremia, with CT and/or MRI findings supportive of PRES when present and exclusion of alternative diagnoses. Results: All patients presented with acute neurological manifestations, including headache, visual disturbances, seizures, and/or altered consciousness, in the context of marked hypertension and uremia. Neuroimaging findings ranged from normal CT/MRI to subtle bilateral occipital hypodensities and, in one case, extensive supra- and infratentorial vasogenic edema with internal hydrocephalus and subependymal edema. In three patients, inadequate volume or solute control on PD prompted temporary or permanent transition to HD to improve blood pressure and fluid management. With antihypertensive therapy, seizure control when required, correction of metabolic disturbances, and optimization of dialysis, all patients recovered clinically, with time to PRES resolution ranging from 7 to 43 days. Conclusions: PRES should be considered in PD patients with new-onset seizures, visual symptoms, or unexplained changes in mental status, particularly during hypertensive crises and uremia. Early CT/MRI, prompt blood pressure control, and careful adjustment of dialysis modality appear important for achieving favorable neurological outcomes.
{"title":"Posterior Reversible Encephalopathy Syndrome in Peritoneal Dialysis Patients: A Four-Case Series.","authors":"Nanda Shajan, Gabrielė Mikšytė, Diana Sukackienė, Giedrė Žulpaitė, Raminta Lukšaitė-Lukštė, Laurynas Rimševičius, Marius Miglinas","doi":"10.3390/jcm15052003","DOIUrl":"10.3390/jcm15052003","url":null,"abstract":"<p><p><b>Background/Objectives:</b> Posterior reversible encephalopathy syndrome (PRES) is a neurological condition characterized by acute neurological symptoms and vasogenic edema, usually affecting the posterior circulation. It is described in end-stage renal disease (ESRD), but its presentation in peritoneal dialysis (PD) is not well defined. We aimed to describe the clinical, radiological, and dialysis-related features of PRES in PD patients and highlight factors relevant for diagnosis and management. <b>Materials and Methods:</b> We conducted a retrospective descriptive case series of four ESRD patients on PD or recently transitioned from PD to hemodialysis (HD) who developed PRES at a single center. Clinical data, laboratory results, dialysis characteristics, and neuroimaging findings were obtained from medical records. PRES was diagnosed based on acute neurological symptoms in the setting of severe hypertension and uremia, with CT and/or MRI findings supportive of PRES when present and exclusion of alternative diagnoses. <b>Results:</b> All patients presented with acute neurological manifestations, including headache, visual disturbances, seizures, and/or altered consciousness, in the context of marked hypertension and uremia. Neuroimaging findings ranged from normal CT/MRI to subtle bilateral occipital hypodensities and, in one case, extensive supra- and infratentorial vasogenic edema with internal hydrocephalus and subependymal edema. In three patients, inadequate volume or solute control on PD prompted temporary or permanent transition to HD to improve blood pressure and fluid management. With antihypertensive therapy, seizure control when required, correction of metabolic disturbances, and optimization of dialysis, all patients recovered clinically, with time to PRES resolution ranging from 7 to 43 days. <b>Conclusions:</b> PRES should be considered in PD patients with new-onset seizures, visual symptoms, or unexplained changes in mental status, particularly during hypertensive crises and uremia. Early CT/MRI, prompt blood pressure control, and careful adjustment of dialysis modality appear important for achieving favorable neurological outcomes.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"15 5","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12985986/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147457841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Shehab Mohamed, Luca Bertolaccini, Roberto Gasparri, Giorgio Lo Iacono, Antonio Mazzella, Monica Casiraghi, Claudia Bardoni, Cristina Diotti, Lorenzo Spaggiari
Background: Chondrosarcomas of the manubrium are exceedingly rare, accounting for approximately 20% of all primary bone malignancies, and present unique challenges in surgical management and reconstruction. Reliable reconstructive strategies for medial clavicular stabilization remain limited.
Case presentation: We report the first documented use of STRATOS bars for unilateral clavicular stabilization following manubrial chondrosarcoma resection. A 19-year-old woman with a poorly differentiated (G3) chondrosarcoma of the manubrium underwent neoadjuvant chemotherapy followed by en bloc resection of the manubrium, medial clavicle, and first rib. Reconstruction and clavicular stabilization were achieved using STRATOS, which is traditionally employed for chest-wall reconstruction. This represents a novel use of the device for medial clavicular stabilization after SCJ resection. At the 6-month follow-up, the patient remained disease-free, with preserved shoulder function and stable reconstruction. STRATOS provided stable fixation, preserved shoulder function, and an excellent cosmetic outcome. A brief review of the literature on sternal chondrosarcoma and reconstruction techniques is also presented.
Conclusion: This unique application expands the reconstructive possibilities of modular titanium systems. It may offer a more reliable biomechanical alternative to traditional fixation methods in cases requiring stability of the shoulder girdle after SCJ resection. Further validation through biomechanical studies and larger case series is warranted.
{"title":"Novel Application of STRATOS for Restoration of Clavicular Stability After Oncologic Sternoclavicular Joint Resection: A Case Report and Review of the Literature.","authors":"Shehab Mohamed, Luca Bertolaccini, Roberto Gasparri, Giorgio Lo Iacono, Antonio Mazzella, Monica Casiraghi, Claudia Bardoni, Cristina Diotti, Lorenzo Spaggiari","doi":"10.3390/jcm15052002","DOIUrl":"10.3390/jcm15052002","url":null,"abstract":"<p><strong>Background: </strong>Chondrosarcomas of the manubrium are exceedingly rare, accounting for approximately 20% of all primary bone malignancies, and present unique challenges in surgical management and reconstruction. Reliable reconstructive strategies for medial clavicular stabilization remain limited.</p><p><strong>Case presentation: </strong>We report the first documented use of STRATOS bars for unilateral clavicular stabilization following manubrial chondrosarcoma resection. A 19-year-old woman with a poorly differentiated (G3) chondrosarcoma of the manubrium underwent neoadjuvant chemotherapy followed by en bloc resection of the manubrium, medial clavicle, and first rib. Reconstruction and clavicular stabilization were achieved using STRATOS, which is traditionally employed for chest-wall reconstruction. This represents a novel use of the device for medial clavicular stabilization after SCJ resection. At the 6-month follow-up, the patient remained disease-free, with preserved shoulder function and stable reconstruction. STRATOS provided stable fixation, preserved shoulder function, and an excellent cosmetic outcome. A brief review of the literature on sternal chondrosarcoma and reconstruction techniques is also presented.</p><p><strong>Conclusion: </strong>This unique application expands the reconstructive possibilities of modular titanium systems. It may offer a more reliable biomechanical alternative to traditional fixation methods in cases requiring stability of the shoulder girdle after SCJ resection. Further validation through biomechanical studies and larger case series is warranted.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"15 5","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12985845/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147458076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Giuseppe Fischetti, Lorenzo Giovannico, Domenico Parigino, Luca Savino, Federica Mazzone, Claudia Leo, Giuseppe Cristiano, Martina Macella, Paola De Santis, Federico Scalese, Eduardo Urgesi, Nicola Di Bari, Concetta Losito, Aldo Domenico Milano, Massimo Padalino, Massimiliano Carrozzini, Tomaso Bottio
Background: To address organ shortage and reduce waitlist mortality, the use of extended criteria donors (ECDs) in heart transplantation is increasing. Methods: We retrospectively analysed outcomes in 236 heart transplant recipients: 140 received standard donor (SD) hearts and 96 received ECD hearts. Results: No significant differences were found in early or mid-term survival between the SD and ECD groups with a 30-day mortality rates of 13% vs. 10% (p = 0.662) and estimated 1-year survival of 75% (95% CI: 62.3-78.3%) and 71% (95% CI: 55.3-76.2%) (p = 0.556), respectively. Mechanical ventilation prior to transplant (p < 0.001), ischemic time (p = 0.022), peripheral vascular disease (p = 0.011), and chronic obstructive pulmonary disease (p = 0.022) were the only independent predictors of mortality. Conclusions: In our cohort, heart transplantation using ECD was not associated with increased early or mid-term adverse events. This approach may help expand the donor pool without compromising post-transplant outcomes.
{"title":"Extended Criteria Donor Use in Heart Transplantation: A Promising Strategy to Expand the Donor Pool.","authors":"Giuseppe Fischetti, Lorenzo Giovannico, Domenico Parigino, Luca Savino, Federica Mazzone, Claudia Leo, Giuseppe Cristiano, Martina Macella, Paola De Santis, Federico Scalese, Eduardo Urgesi, Nicola Di Bari, Concetta Losito, Aldo Domenico Milano, Massimo Padalino, Massimiliano Carrozzini, Tomaso Bottio","doi":"10.3390/jcm15051980","DOIUrl":"10.3390/jcm15051980","url":null,"abstract":"<p><p><b>Background</b>: To address organ shortage and reduce waitlist mortality, the use of extended criteria donors (ECDs) in heart transplantation is increasing. <b>Methods</b>: We retrospectively analysed outcomes in 236 heart transplant recipients: 140 received standard donor (SD) hearts and 96 received ECD hearts. <b>Results</b>: No significant differences were found in early or mid-term survival between the SD and ECD groups with a 30-day mortality rates of 13% vs. 10% (<i>p</i> = 0.662) and estimated 1-year survival of 75% (95% CI: 62.3-78.3%) and 71% (95% CI: 55.3-76.2%) (<i>p</i> = 0.556), respectively. Mechanical ventilation prior to transplant (<i>p</i> < 0.001), ischemic time (<i>p</i> = 0.022), peripheral vascular disease (<i>p</i> = 0.011), and chronic obstructive pulmonary disease (<i>p</i> = 0.022) were the only independent predictors of mortality. <b>Conclusions</b>: In our cohort, heart transplantation using ECD was not associated with increased early or mid-term adverse events. This approach may help expand the donor pool without compromising post-transplant outcomes.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"15 5","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12985408/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147457542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pier Giuseppe Ruggeri, Alberto Carnicci, Matilde Buzzi, Fabrizio Giansanti, Rita Mencucci
Background/Objectives: During cataract surgery, topical anesthesia is routinely achieved through the instillation of topical anesthetic eye drops, while different agents may be applied to the corneal surface during the procedure to support lubrication and protection. The impact of these intraoperative strategies on corneal integrity and postoperative ocular surface recovery remains an area of clinical interest. This study aimed to compare the intraoperative and postoperative effects of applying a topical anesthetic gel (Ophtesic, Horus Pharma) on the corneal surface versus the use of balanced salt solution (BSS) during cataract surgery. Methods: In this longitudinal, observational prospective study, 24 eyes of 24 patients undergoing phacoemulsification received either topical anesthetic gel (n = 15) or BSS irrigation (n = 9). Central corneal thickness (CCT) and epithelial thickness were measured preoperatively and on postoperative days 1, 5, and 15 using anterior segment optical coherence tomography (AS-OCT). Basal epithelial cell (BEC) density was assessed by in vivo confocal microscopy (IVCM), while OSDI score, non-invasive breakup time (NI-BUT), and Schirmer test I values were evaluated preoperatively and on postoperative days 5 and 15. Patient and surgeon satisfaction were rated using a Likert-like scale. Results: Both groups showed increased CCT and epithelial thickness at day 1. In the gel group, CCT returned to baseline by day 15 (p = 0.361), and epithelial thickness normalized by day 5 (p = 0.066). In the BSS group, CCT remained elevated at day 15 (p < 0.05), and epithelial thickness decreased at day 5 (p < 0.05) before returning to baseline. BEC density normalized at day 15 in the gel group (p = 0.107) but remained altered in the BSS group (p < 0.05). NI-BUT Schirmer I, and OSDI showed a trend toward faster recovery in the gel group than in the BSS group. Conclusions: In this exploratory study, intraoperative application of a topical anesthetic gel appeared to support early normalization of corneal and tear film parameters while providing effective anesthesia. Further studies are warranted to confirm these observations and evaluate potential long-term benefits.
{"title":"Intraoperative Use of a Topical Anesthetic Gel Versus Balanced Salt Solution During Cataract Surgery: Effects on Corneal Structure and Ocular Surface.","authors":"Pier Giuseppe Ruggeri, Alberto Carnicci, Matilde Buzzi, Fabrizio Giansanti, Rita Mencucci","doi":"10.3390/jcm15051992","DOIUrl":"10.3390/jcm15051992","url":null,"abstract":"<p><p><b>Background/Objectives:</b> During cataract surgery, topical anesthesia is routinely achieved through the instillation of topical anesthetic eye drops, while different agents may be applied to the corneal surface during the procedure to support lubrication and protection. The impact of these intraoperative strategies on corneal integrity and postoperative ocular surface recovery remains an area of clinical interest. This study aimed to compare the intraoperative and postoperative effects of applying a topical anesthetic gel (Ophtesic, Horus Pharma) on the corneal surface versus the use of balanced salt solution (BSS) during cataract surgery. <b>Methods:</b> In this longitudinal, observational prospective study, 24 eyes of 24 patients undergoing phacoemulsification received either topical anesthetic gel (n = 15) or BSS irrigation (n = 9). Central corneal thickness (CCT) and epithelial thickness were measured preoperatively and on postoperative days 1, 5, and 15 using anterior segment optical coherence tomography (AS-OCT). Basal epithelial cell (BEC) density was assessed by in vivo confocal microscopy (IVCM), while OSDI score, non-invasive breakup time (NI-BUT), and Schirmer test I values were evaluated preoperatively and on postoperative days 5 and 15. Patient and surgeon satisfaction were rated using a Likert-like scale. <b>Results:</b> Both groups showed increased CCT and epithelial thickness at day 1. In the gel group, CCT returned to baseline by day 15 (<i>p</i> = 0.361), and epithelial thickness normalized by day 5 (<i>p</i> = 0.066). In the BSS group, CCT remained elevated at day 15 (<i>p</i> < 0.05), and epithelial thickness decreased at day 5 (<i>p</i> < 0.05) before returning to baseline. BEC density normalized at day 15 in the gel group (<i>p</i> = 0.107) but remained altered in the BSS group (<i>p</i> < 0.05). NI-BUT Schirmer I, and OSDI showed a trend toward faster recovery in the gel group than in the BSS group. <b>Conclusions:</b> In this exploratory study, intraoperative application of a topical anesthetic gel appeared to support early normalization of corneal and tear film parameters while providing effective anesthesia. Further studies are warranted to confirm these observations and evaluate potential long-term benefits.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"15 5","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12985571/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147457566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Alma L Guzmán-Gurrola, Laura González-López, Jonathan S Chávez-Íñiguez, Mariana Verduzco Vázquez, Efraín I Flores-Hernández, José A Novoa-Burquez, Maria G Zavala-Cerna
Background/Objectives: Long COVID has emerged as a significant public health concern, characterized by persistent symptoms following SARS-CoV-2 infection. Cognitive impairment is a common sequela, particularly among older adults (OAs). Although olfactory dysfunction and malnutrition have been previously associated with cognitive decline, it remains elusive to what extent sex-specific variations in these and additional factors will be pivotal to guiding targeted interventions in a sex-specific manner. To fill this gap in knowledge, we undertook a study with the purpose of investigating the contribution of sex-specific risk factors to the development of cognitive impairment (CI) in a cohort of OAs hospitalized with long COVID. Methods: We undertook a cross-sectional study among OAs hospitalized at a geriatric care unit. Olfactory function was assessed using the Sniffin' Stick Test. Cognitive impairment was evaluated by the Mini-Mental State Examination, and nutritional status was assessed with the Mini Nutritional Assessment (MNA). Statistical analyses included linear regression. Results: A total of 45 patients with long COVID were included, of whom 51% were female. The prevalence of CI was lower in men compared to women. In the single variable analysis, nutritional factors were associated with CI only in women; importantly, the loss of olfactory function was associated with CI in the whole group and to CI in women after multivariate analysis. Conclusions: Olfactory dysfunction is a potential biomarker for cognitive impairment in OAs with long COVID in a sex-specific manner. In our study nutritional status and probable obesity could be additional factors associated with CI; nevertheless, this was not confirmed in our multivariate analysis; therefore, this hypothesis would need to be tested in larger studies.
背景/目的:长冠状病毒已成为一个重大的公共卫生问题,其特征是SARS-CoV-2感染后持续出现症状。认知障碍是常见的后遗症,特别是在老年人(oa)中。虽然嗅觉功能障碍和营养不良以前与认知能力下降有关,但这些和其他因素的性别特异性差异在多大程度上对指导以性别特异性方式进行有针对性的干预至关重要,仍然是难以捉摸的。为了填补这一知识空白,我们开展了一项研究,目的是调查性别特异性危险因素对长期COVID住院的oa队列中认知功能障碍(CI)发展的贡献。方法:我们对在老年护理单位住院的oa进行了横断面研究。使用嗅探棒试验评估嗅觉功能。采用Mini- mental State Examination评估认知功能障碍,采用Mini- nutrition Assessment (MNA)评估营养状况。统计分析包括线性回归。结果:共纳入45例长冠肺炎患者,其中女性占51%。男性CI患病率低于女性。在单变量分析中,营养因素仅与女性CI相关;重要的是,在多变量分析后,嗅觉功能的丧失与整个组的CI和女性的CI相关。结论:嗅觉功能障碍是长冠状病毒OAs患者认知功能障碍的潜在生物标志物,具有性别特异性。在我们的研究中,营养状况和可能的肥胖可能是与CI相关的其他因素;然而,这在我们的多变量分析中没有得到证实;因此,这一假设需要在更大规模的研究中进行检验。
{"title":"Sex-Specific Differences in Nutritional Status and Olfaction in Association with Cognitive Impairment Amongst Older Adults with Long COVID Syndrome.","authors":"Alma L Guzmán-Gurrola, Laura González-López, Jonathan S Chávez-Íñiguez, Mariana Verduzco Vázquez, Efraín I Flores-Hernández, José A Novoa-Burquez, Maria G Zavala-Cerna","doi":"10.3390/jcm15051994","DOIUrl":"10.3390/jcm15051994","url":null,"abstract":"<p><p><b>Background/Objectives</b>: Long COVID has emerged as a significant public health concern, characterized by persistent symptoms following SARS-CoV-2 infection. Cognitive impairment is a common sequela, particularly among older adults (OAs). Although olfactory dysfunction and malnutrition have been previously associated with cognitive decline, it remains elusive to what extent sex-specific variations in these and additional factors will be pivotal to guiding targeted interventions in a sex-specific manner. To fill this gap in knowledge, we undertook a study with the purpose of investigating the contribution of sex-specific risk factors to the development of cognitive impairment (CI) in a cohort of OAs hospitalized with long COVID. <b>Methods</b>: We undertook a cross-sectional study among OAs hospitalized at a geriatric care unit. Olfactory function was assessed using the Sniffin' Stick Test. Cognitive impairment was evaluated by the Mini-Mental State Examination, and nutritional status was assessed with the Mini Nutritional Assessment (MNA). Statistical analyses included linear regression. <b>Results</b>: A total of 45 patients with long COVID were included, of whom 51% were female. The prevalence of CI was lower in men compared to women. In the single variable analysis, nutritional factors were associated with CI only in women; importantly, the loss of olfactory function was associated with CI in the whole group and to CI in women after multivariate analysis. <b>Conclusions</b>: Olfactory dysfunction is a potential biomarker for cognitive impairment in OAs with long COVID in a sex-specific manner. In our study nutritional status and probable obesity could be additional factors associated with CI; nevertheless, this was not confirmed in our multivariate analysis; therefore, this hypothesis would need to be tested in larger studies.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"15 5","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12985874/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147458046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Iñigo Rubio-Baines, Luigi Camporota, Duilio González-Delgado, Gemma Echarri, Maria Carmen Sala-Trull, Pablo Montero-López, Marc Vives
Background: Human serum albumin (HSA), the most abundant plasma protein, is essential for oncotic pressure, endothelial protection, drug binding, and immune modulation. Despite its widespread clinical use since the 1940s, its therapeutic benefit in critically ill patients remains debated. This narrative review summarizes current evidence on HSA use in common intensive care scenarios. Clinical Applications: In hepatorenal syndrome (HRS), albumin combined with vasoconstrictors like terlipressin improves renal function and survival. In spontaneous bacterial peritonitis (SBP), albumin lowers the risk of acute kidney injury and mortality, particularly in high-risk cirrhotic patients. Post-paracentesis albumin reduces circulatory dysfunction and may enhance survival in cirrhosis. For septic shock, trials show no overall mortality benefit over crystalloids, though albumin may offer hemodynamic advantages in specific subgroups. In acute respiratory distress syndrome (ARDS), albumin improves oxygenation in hypoalbuminemic patients, without survival benefits. During major cardiac or abdominal surgery, albumin reduces fluid needs and postoperative complications, especially in hypoalbuminemic individuals. In acute brain injury, albumin's role is controversial: it may aid recovery after cerebral hemorrhage, but can worsen outcomes in traumatic brain injury. In trauma and ECMO patients, albumin may stabilize hemodynamics and improve outcomes in selected cases. Conclusions: Inappropriate albumin use remains common, and evidence on its optimal concentration, dose, timing, and patient selection is limited. HSA is safe and beneficial in specific situations. Routine use should follow evidence-based guidelines. Future research must identify patients who are most likely to benefit and clarify optimal dosing strategies, concentrations, and therapeutic goals.
{"title":"Use of Human Serum Albumin in Critically Ill Patients: A Narrative Review.","authors":"Iñigo Rubio-Baines, Luigi Camporota, Duilio González-Delgado, Gemma Echarri, Maria Carmen Sala-Trull, Pablo Montero-López, Marc Vives","doi":"10.3390/jcm15051981","DOIUrl":"10.3390/jcm15051981","url":null,"abstract":"<p><p><b>Background</b>: Human serum albumin (HSA), the most abundant plasma protein, is essential for oncotic pressure, endothelial protection, drug binding, and immune modulation. Despite its widespread clinical use since the 1940s, its therapeutic benefit in critically ill patients remains debated. This narrative review summarizes current evidence on HSA use in common intensive care scenarios. <b>Clinical Applications</b>: In hepatorenal syndrome (HRS), albumin combined with vasoconstrictors like terlipressin improves renal function and survival. In spontaneous bacterial peritonitis (SBP), albumin lowers the risk of acute kidney injury and mortality, particularly in high-risk cirrhotic patients. Post-paracentesis albumin reduces circulatory dysfunction and may enhance survival in cirrhosis. For septic shock, trials show no overall mortality benefit over crystalloids, though albumin may offer hemodynamic advantages in specific subgroups. In acute respiratory distress syndrome (ARDS), albumin improves oxygenation in hypoalbuminemic patients, without survival benefits. During major cardiac or abdominal surgery, albumin reduces fluid needs and postoperative complications, especially in hypoalbuminemic individuals. In acute brain injury, albumin's role is controversial: it may aid recovery after cerebral hemorrhage, but can worsen outcomes in traumatic brain injury. In trauma and ECMO patients, albumin may stabilize hemodynamics and improve outcomes in selected cases. <b>Conclusions</b>: Inappropriate albumin use remains common, and evidence on its optimal concentration, dose, timing, and patient selection is limited. HSA is safe and beneficial in specific situations. Routine use should follow evidence-based guidelines. Future research must identify patients who are most likely to benefit and clarify optimal dosing strategies, concentrations, and therapeutic goals.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"15 5","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12986204/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147458064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Vanja Silić, Nikolina Bašic-Jukić, Ivan Romić, Igor Petrović, Daniela Bandić Pavlović, Goran Pavlek, Emil Kinda
Background: Sepsis is one of the leading causes of early death after a liver transplant, with a frequency of up to 45% and a high death rate of 50% in more severe forms. Standard diagnostic and therapeutic algorithms are often not applicable to this specific population, where immunosuppression, reperfusion injury, and systemic inflammation overlap and generate a clinical picture that is significantly different from sepsis in immunocompetent patients. Methods: This paper analyzes the available literature and clinical experiences of characteristic immune and hemodynamic profiles of sepsis after liver transplants. Biomarkers (IL-6, IL-10, HLA-DR, lactate, and IgM) are discussed as tools for assessing immune status and guiding timely interventions, including the early application of continuous renal replacement therapy (CRRT) and the selective use of IgM-enriched immunoglobulins. Results: Sepsis after liver transplantation frequently unfolds in two phases, an initial hyper-inflammatory response driven by cytokine release and reperfusion injury and a second phase of secondary immunoparalysis characterized by reduced HLA-DR expression and increased anti-inflammatory signaling. The immunometabolic shift appears to influence the clinical course and may inform therapeutic decision-making. The immunoparalysis phase is accompanied by mitochondrial dysfunction and impaired vascular reactivity. This type of mechanism contributes to hemodynamic instability and a reduced response to standard therapy. Individualized monitoring and early use of hemofiltration and immunomodulatory measures can improve results in carefully selected patients. Conclusions: In this setting, an individualized immunometabolic approach may complement standard sepsis management in liver transplant recipients. The introduction of biomarkers of immune function into routine practice and the recognition of early signs of exhaustion of the immune response can assist in timely therapeutic decision-making and improve survival.
{"title":"Post-Transplant Sepsis After Liver Transplantation: Clinical Characteristics and Therapeutic Challenges.","authors":"Vanja Silić, Nikolina Bašic-Jukić, Ivan Romić, Igor Petrović, Daniela Bandić Pavlović, Goran Pavlek, Emil Kinda","doi":"10.3390/jcm15051989","DOIUrl":"10.3390/jcm15051989","url":null,"abstract":"<p><p><b>Background:</b> Sepsis is one of the leading causes of early death after a liver transplant, with a frequency of up to 45% and a high death rate of 50% in more severe forms. Standard diagnostic and therapeutic algorithms are often not applicable to this specific population, where immunosuppression, reperfusion injury, and systemic inflammation overlap and generate a clinical picture that is significantly different from sepsis in immunocompetent patients. <b>Methods:</b> This paper analyzes the available literature and clinical experiences of characteristic immune and hemodynamic profiles of sepsis after liver transplants. Biomarkers (IL-6, IL-10, HLA-DR, lactate, and IgM) are discussed as tools for assessing immune status and guiding timely interventions, including the early application of continuous renal replacement therapy (CRRT) and the selective use of IgM-enriched immunoglobulins. <b>Results:</b> Sepsis after liver transplantation frequently unfolds in two phases, an initial hyper-inflammatory response driven by cytokine release and reperfusion injury and a second phase of secondary immunoparalysis characterized by reduced HLA-DR expression and increased anti-inflammatory signaling. The immunometabolic shift appears to influence the clinical course and may inform therapeutic decision-making. The immunoparalysis phase is accompanied by mitochondrial dysfunction and impaired vascular reactivity. This type of mechanism contributes to hemodynamic instability and a reduced response to standard therapy. Individualized monitoring and early use of hemofiltration and immunomodulatory measures can improve results in carefully selected patients. <b>Conclusions:</b> In this setting, an individualized immunometabolic approach may complement standard sepsis management in liver transplant recipients. The introduction of biomarkers of immune function into routine practice and the recognition of early signs of exhaustion of the immune response can assist in timely therapeutic decision-making and improve survival.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"15 5","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12985828/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147457951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objectives: This study systematically evaluated and quantitatively synthesized preclinical evidence on the effects of magnesium (Mg) incorporation into or coating of titanium dental implants on osseointegration and peri-implant bone formation. Methods: Electronic searches of PubMed, Scopus, and Web of Science were performed up to May 2025 to identify animal studies evaluating Mg-modified titanium implants. Eligible studies compared Mg-incorporated or Mg-coated implants with non-modified titanium controls and reported quantitative histomorphometric outcomes. Primary outcomes included the values of bone-to-implant contact (BIC) and bone area (BA) around implants. Study quality was assessed using the ARRIVE 2.0 guidelines. Meta-analyses were performed using weighted mean differences with 95% confidence intervals under fixed- or random-effects models based on heterogeneity. Results: Eleven preclinical animal studies conducted in rabbit and rat models were included. Mg was incorporated using various surface-modification techniques, including ion implantation, Mg-substituted hydroxyapatite coatings, mesoporous titania layers, and nanotubular structures. Overall, the studies' quality was high, with most studies rated as excellent and with a low-to-moderate risk of bias. Furthermore, the meta-analysis revealed a significant increase in BIC for Mg-modified implants compared with uncoated implants (Z = 4.38, p < 0.001), implying improved osseointegration. Meanwhile, pooled BA values showed no significant differences between the groups (Z = 0.93, p = 0.35). Conclusions: Mg coating onto or incorporation into titanium implant surfaces can improve BIC in preclinical models, indicating improved osseointegration in the early stages.
目的:系统评价和定量合成钛牙种植体中掺入或涂覆镁对骨整合和种植体周围骨形成影响的临床前证据。方法:截至2025年5月,对PubMed、Scopus和Web of Science进行电子检索,以确定评估mg修饰钛植入物的动物研究。符合条件的研究比较了含镁或包覆镁植入物与未修饰的钛对照物,并报告了定量组织形态学结果。主要结果包括骨与种植体接触(BIC)和种植体周围骨面积(BA)的值。使用ARRIVE 2.0指南评估研究质量。在基于异质性的固定效应或随机效应模型下,采用加权平均差异和95%置信区间进行meta分析。结果:纳入11项兔、大鼠临床前动物实验。镁通过各种表面修饰技术被掺入,包括离子注入、镁取代羟基磷灰石涂层、介孔二氧化钛层和纳米管结构。总体而言,这些研究的质量很高,大多数研究被评为优秀,偏倚风险为低至中等。此外,荟萃分析显示,与未涂覆种植体相比,mg修饰种植体的BIC显著增加(Z = 4.38, p < 0.001),这意味着骨整合得到改善。合并BA值组间差异无统计学意义(Z = 0.93, p = 0.35)。结论:在临床前模型中,钛种植体表面涂覆或掺入Mg可以改善BIC,表明早期骨整合得到改善。
{"title":"Effect of Magnesium-Modified Titanium Implants on Osseointegration: A Systematic Review and Meta-Analysis of Preclinical Studies.","authors":"Ali Alenezi, Dhafer Alasmari","doi":"10.3390/jcm15051987","DOIUrl":"10.3390/jcm15051987","url":null,"abstract":"<p><p><b>Objectives</b>: This study systematically evaluated and quantitatively synthesized preclinical evidence on the effects of magnesium (Mg) incorporation into or coating of titanium dental implants on osseointegration and peri-implant bone formation. <b>Methods</b>: Electronic searches of PubMed, Scopus, and Web of Science were performed up to May 2025 to identify animal studies evaluating Mg-modified titanium implants. Eligible studies compared Mg-incorporated or Mg-coated implants with non-modified titanium controls and reported quantitative histomorphometric outcomes. Primary outcomes included the values of bone-to-implant contact (BIC) and bone area (BA) around implants. Study quality was assessed using the ARRIVE 2.0 guidelines. Meta-analyses were performed using weighted mean differences with 95% confidence intervals under fixed- or random-effects models based on heterogeneity. <b>Results</b>: Eleven preclinical animal studies conducted in rabbit and rat models were included. Mg was incorporated using various surface-modification techniques, including ion implantation, Mg-substituted hydroxyapatite coatings, mesoporous titania layers, and nanotubular structures. Overall, the studies' quality was high, with most studies rated as excellent and with a low-to-moderate risk of bias. Furthermore, the meta-analysis revealed a significant increase in BIC for Mg-modified implants compared with uncoated implants (Z = 4.38, <i>p</i> < 0.001), implying improved osseointegration. Meanwhile, pooled BA values showed no significant differences between the groups (Z = 0.93, <i>p</i> = 0.35). <b>Conclusions</b>: Mg coating onto or incorporation into titanium implant surfaces can improve BIC in preclinical models, indicating improved osseointegration in the early stages.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"15 5","pages":""},"PeriodicalIF":2.9,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12986129/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147457650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}